01409nam 2200385Ia 450 991069692780332120230902161715.0(CKB)5470000002383616(OCoLC)557250072(EXLCZ)99547000000238361620100317d2000 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] waiver of in vivo bioavailability studies for immediate-release soild oral dosage forms based on a biopharmaceutics classification systemRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,[2000]1 electronic resource (13 pages)"BP.""August 2000."Guidance for industry DrugsDosage formsBioavailabilityUnited StatesDrugsUnited StatesTherapeutic equivalencyBiopharmaceuticsDrugsDosage formsBioavailabilityDrugsTherapeutic equivalency.Biopharmaceutics.Center for Drug Evaluation and Research (U.S.)GPOGPOBOOK9910696927803321Guidance for industry3434577UNINA